InvestorsHub Logo
Followers 56
Posts 8436
Boards Moderated 0
Alias Born 05/14/2015

Re: Goldstrike post# 32858

Saturday, 08/04/2018 8:51:36 AM

Saturday, August 04, 2018 8:51:36 AM

Post# of 118364
It could be huge but odds are it won't.

How do I know? Well, follow the money. Unfortunately, you can't because Koos doesn't have any for his companies. He has 4 tickers that are losers. He has an FDA P1 approval but he couldn't find money for it. Many were saying it would cure cancer. Well, if so why hasn't he been able to find anyone to help fund p1 trials?

Look, the ridiculousness of the wishful thinking doesn't make for a very rational investment thesis.

Cash is needed and cash is what Koos has no idea how to get. He's proven that time and time again.

Koos is only keeping his companies alive with creative financial moves that are suspect at best. And he's failing at that.

What will koos do when he finds out he can't get anyone to fund his NERF2 molecule?

Lilly surely isn't funding it. All it is doing is allowing Koos to use their molecule library. Maybe if they see some promise will they step up but that remains to be seen. LEt's hope that scenario happens or NERF2 will die on the vine just like Hema and Decell.

Again, facts that no one can disprove.

I'm still waiting for the answer to my question, "What business success has Koos ever had?" Answer that others know but won't answer: HE HAS NONE